SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.75%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$289M
AUM Growth
+$289M
(-42%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
39.85%
Holding
261
New
44
Increased
40
Reduced
58
Closed
60
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.3M |
| 2 |
Abbott
ABT
|
$10.4M |
| 3 |
Outlook Therapeutics
OTLK
|
$7.04M |
| 4 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$5.95M |
| 5 |
SHPG
Shire pic
SHPG
|
$5.44M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$22.4M |
| 2 |
Plus Therapeutics
PSTV
|
$11.2M |
| 3 |
Biogen
BIIB
|
$6.55M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.88M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$2.84M |
Sector Composition
| 1 | Healthcare | 85.34% |
| 2 | Industrials | 0.77% |
| 3 | Consumer Staples | 0.45% |
| 4 | Consumer Discretionary | 0.43% |
| 5 | Technology | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXZ
26
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $2.81M | 0.15% |
260,000
-40,000
| -13% | -$432K |
|
|
EDAP
27
EDAP TMS
EDAP
$98.7M
| $2.8M | 0.15% |
+847,225
| New | +$2.8M |
|
|
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.79M | 0.15% |
71,943
-6,057
| -8% | -$235K |
|
|
PVLA
29
Palvella Therapeutics, Inc. Common Stock
PVLA
$581M
| $2.6M | 0.14% |
1,615,992
+1,440,992
| +823% | +$2.32M |
|
|
OPGN
30
DELISTED
OpGen, Inc
OPGN
| $2.47M | 0.13% |
+1,625,000
| New | +$2.47M |
|
31
Adverum Biotechnologies
ADVM
$67.1M
| $2.47M | 0.13% |
779,926
+239,294
| +44% | +$756K |
|
|
SIOX
32
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.44M | 0.13% |
190,000
+155,960
| +458% | +$2M |
|
33
VistaGen Therapeutics
VTGN
$110M
| $2.43M | 0.13% |
+623,317
| New | +$2.43M |
|
|
34
Biogen
BIIB
$20.8B
| $2.42M | 0.13% |
10,000
-27,077
| -73% | -$6.55M |
|
|
ZGNX
35
DELISTED
Zogenix, Inc.
ZGNX
| $2.33M | 0.12% |
289,200
+34,776
| +14% | +$280K |
|
|
IRD
36
Opus Genetics, Inc. Common Stock
IRD
$74.9M
| $2.28M | 0.12% |
9,071,168
-4,141,086
| -31% | -$1.04M |
|
|
SAGE
37
DELISTED
Sage Therapeutics
SAGE
| $2.08M | 0.11% |
68,950
-31,050
| -31% | -$935K |
|
38
Imunon
IMNN
$14.4M
| $1.93M | 0.1% |
1,519,365
+1,500,576
| +7,986% | +$1.91M |
|
39
Palisade Bio
PALI
$6.06M
| $1.89M | 0.1% |
+6,503,800
| New | +$1.89M |
|
|
FWP
40
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.86M | 0.1% |
102,135
+25,350
| +33% | +$461K |
|
|
BDSI
41
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.85M | 0.1% |
785,799
+229,830
| +41% | +$542K |
|
|
CGRN
42
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $1.85M | 0.1% |
+1,336,901
| New | +$1.85M |
|
43
Opko Health
OPK
$1.09B
| $1.78M | 0.09% |
190,554
+78,543
| +70% | +$734K |
|
|
ADYX
44
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $1.68M | 0.09% |
1,500,000
-467,208
| -24% | -$523K |
|
|
RDHL
45
Redhill Biopharma
RDHL
$2.94M
| $1.61M | 0.08% |
147,500
-9,023
| -6% | -$98.6K |
|
|
FOMX
46
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.61M | 0.08% |
253,706
-6,694
| -3% | -$42.5K |
|
47
FibroGen
FGEN
$48.5M
| $1.6M | 0.08% |
97,274
-11,826
| -11% | -$194K |
|
|
MNTA
48
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.57M | 0.08% |
145,600
-134,625
| -48% | -$1.45M |
|
|
WGBS
49
DELISTED
WaferGen Bio-systems, Inc.
WGBS
| $1.53M | 0.08% |
1,867,250
+671,780
| +56% | +$552K |
|
|
FLXN
50
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.51M | 0.08% |
100,800
+54,445
| +117% | +$815K |
|